- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.09.24 | VAPOTHERM INC - 15-12G, Securities registration termination | 2 | SEC Filings | ||
| VAPOTHERM Aktie jetzt für 0€ handeln | |||||
| 24.09.24 | Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth | 4 | Investing.com | ||
| 20.09.24 | Vapotherm, Inc.: Vapotherm Announces Closing of Merger | 574 | PR Newswire | EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and... ► Artikel lesen | |
| 19.09.24 | VAPOTHERM INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08.24 | Vapotherm, Inc.: Vapotherm Reports Second Quarter 2024 Financial Results | 165 | PR Newswire | EXETER, N.H., Aug. 12, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced second quarter 2024 financial results and related highlights.
Second Quarter... ► Artikel lesen | |
| 17.06.24 | Vapotherm, Inc.: Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private | 212 | PR Newswire | EXETER, N.H., June 17, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has signed a definitive merger agreement with a newly-formed entity... ► Artikel lesen | |
| 09.05.24 | Vapotherm, Inc.: Vapotherm Reports First Quarter 2024 Financial Results | 301 | PR Newswire | EXETER, N.H., May 9, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced first quarter 2024 financial results and related highlights.
First Quarter... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,230 | +2,00 % | Sparprogramm von Fresenius zahlt sich aus - Überraschend gutes Schlussquartal | BAD HOMBURG (dpa-AFX) - Beim Fresenius-Konzern haben sich im vergangenen Jahr der Umbau und das Sparprogramm ausgezahlt. Zudem profitierte der Dax-Konzern von guten Geschäften der Generikatochter Kabi... ► Artikel lesen | |
| MEDTRONIC | 89,43 | -0,59 % | Medtronic Launches Bold 10-Year Global Initiative To Propel 1M Low-Income Students Into Health Tech Careers | Medtronic Spark will provide young people from low-income households the skills needed for well-paying jobs in a growing industry facing a global workforce shortage CLAREGALWAY, IE / ACCESS Newswire... ► Artikel lesen | |
| INTUITIVE SURGICAL | 540,40 | -0,09 % | Aktie von Intuitive Surgical deutlich im Minus (540,00 €) | Zu den großen Verlierern am Aktienmarkt zählt am Dienstag das Wertpapier von Intuitive Surgical . Der Kurs des Papiers sackt kräftig ab. Ein Abschlag von 4,42 Prozent zeigt die Kurstafel für die Aktie... ► Artikel lesen | |
| THERMO FISHER | 496,95 | -0,50 % | Thermo Fisher Scientific To Buy Solventum's Purification And Filtration Business For $4.1 Bln Cash | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) announced Tuesday that the company has entered into a definitive agreement with Solventum Corp. (SOLV) to acquire its Purification... ► Artikel lesen | |
| ROKU | 76,50 | -0,08 % | Citizens JMP reiterates Roku stock with $115 target | ||
| BECTON DICKINSON | 219,00 | +0,46 % | Staar Surgical, BD, Acutus Medical announce layoffs in Southern California | ||
| DEXCOM | 82,06 | -0,01 % | DexCom Inc. Q4 Income Falls | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM) released a profit for fourth quarter that decreased from last yearThe company's bottom line totaled $151.7 million, or $0.38 per share. This compares... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 99,00 | -1,98 % | Aktie von Boston Scientific kaum gefragt: Kurs bricht um 5,04 Prozent ein (94,4275 €) | Am US-amerikanischen Aktienmarkt fällt derzeit die Boston Scientific-Aktie negativ auf. Der Titel verbilligt sich heute deutlich. Ein Abschlag von 5,04 Prozent zeigt die Kurstafel für der Anteilsschein... ► Artikel lesen | |
| RESMED | 223,50 | +0,45 % | ResMed Inc.: ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep | New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least once... ► Artikel lesen | |
| BAXTER | 33,125 | -0,39 % | Dividendenbekanntmachungen (28.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,32 USD 0,3078 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,16 USD 0,1539 EUR AGNC INVESTMENT... ► Artikel lesen | |
| DAVITA | 139,35 | +2,05 % | Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse | NORTHAMPTON, MA / ACCESS Newswire / February 28, 2025 / Ansel, Home Hemodialysis Registered Nurse at DaVita, is a DaVita Global Nurse from the Philippines and was recruited while working as an international... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,726 | +2,98 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| ZIMMER BIOMET | 100,50 | -0,05 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer | WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando | BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| TANDEM DIABETES | 20,730 | +4,49 % | Bernstein downgrades Tandem Diabetes on market share loss concerns |
Das Unternehmen VAPOTHERM INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VAPOTHERM INC finden Sie auf Wallstreet Online.
